Policy & advocacy
Government and public-health decision-support view.
Illustrative operational scenarios; historical laboratory evidence is identified separately. No live surveillance, integrations or AI models are connected.
National AMR indicator
31.7%
+1.8% current cycle
Policy signals
7
3 high priority
Intervention areas
12
Across 6 regions
Stakeholder groups
24
illustrative network
Public-health priorities
Immediate review
Regional expansion
Primary-care focus
Pilot stage
Policy signal
Eastern Province CRE trend exceeds the illustrative review threshold.
Intervention area
Strengthen ICU infection-prevention audit and feedback.
Stakeholder view
Convene hospitals, laboratories and stewardship leads.
Advocacy brief
Translate regional AMR burden into accessible policy messages.
Policy documents
National AMR situation brief
illustrative document · v2.0
Stewardship intervention note
illustrative document · v3.0
One Health coordination framework
illustrative document · v4.0
Policy actions from the SAIR policy report
Integrated surveillance
Connect human, animal and environmental surveillance through GLASS, InFARM and ANIMUSE-aligned reporting.
Antimicrobial consumption and use
Monitor AMC and AMU with the AWaRe classification to guide access, watch and reserve decisions.
Stewardship programmes
Institutionalise antimicrobial stewardship with clinical decision support in hospitals and primary care.
Priority pathogens
Align national priorities with the WHO Bacterial Priority Pathogen List and regional resistance patterns.
Research and development
Support research, diagnostics and partnerships such as GARDP and multi-partner funding mechanisms.
Governance and coordination
One national framework and a global leaders approach for cross-sector accountability.
Programme recommendations
- 1Potentiate evidence through research development and data monitoring of risk analysis and stratification, especially for foodborne antimicrobial resistance.
- 2Implement an effective surveillance system that is active, sentinel and AI-supported.
- 3Set up community health needs assessments covering perceived, expressed, absolute and relative needs.
- 4Expand knowledge through professional education, clinical training and laboratory apprenticeship.
- 5Reduce disease burden by ensuring antibiotics are prescribed following rapid and efficient diagnosis.
- 6Build globally driven national guidelines for the most pressing resistance priorities.
- 7Strengthen open access to surveillance data and sharing between national and international efforts.
- 8Coordinate one governance framework across MOH, NGHA, MEWA and SFDA, aligned with the WHO–FAO–WOAH model.
Sustainable Development Goal alignment
SDG 2
Zero hunger
Antimicrobial use in food production and foodborne resistance.
SDG 3
Good health and well-being
Reducing morbidity, mortality and the burden of resistant infection.
SDG 4
Quality education
Professional education, clinical training and curriculum development.
SDG 6
Clean water and sanitation
Water, wastewater and environmental transmission pathways.
SDG 8
Decent work and economic growth
Protecting productivity and reducing economic loss from resistance.
SDG 12
Responsible consumption
Responsible antimicrobial consumption and stewardship.
SDG 16
Peace, justice and strong institutions
Governance, regulation and accountable institutions.
SDG 17
Partnerships for the goals
Uniting health, educational, government and civil-society partners.
Operational values are simulated. Historical records and source-listed forecasts retain their original attribution; they are not measured GermQ outcomes.